Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 4/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 13/20 | 0.51 |
| ▸ | CA2 | P00918 | 13/20 | 0.51 |
| ▸ | SLC10A2 | Q12908 | 1/20 | 0.46 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12132063 | 1.00 | GPBAR1 (0.66) | GPBAR1LMNAKMT2ATDP1CA1 | |
| SCHEMBL16221730 | 0.91 | LMNA (0.67) | LMNAKMT2ATDP1CA1CA2 | |
| SCHEMBL13411119 | 0.91 | LMNA (0.67) | LMNAKMT2ATDP1CA1CA2 | |
| SCHEMBL19050825 | 0.91 | LMNA (0.67) | LMNAKMT2ATDP1CA1CA2 | |
| SCHEMBL24861649 | 0.91 | LMNA (0.67) | LMNAKMT2ATDP1CA1CA2 | |
| SCHEMBL24667644 | 0.91 | LMNA (0.67) | LMNAKMT2ATDP1CA1CA2 | |
| SCHEMBL17115153 | 0.91 | LMNA (0.67) | LMNAKMT2ATDP1CA1CA2 | |
| SCHEMBL10083783 | 0.91 | LMNA (0.67) | LMNAKMT2ATDP1CA1CA2 | |
| SCHEMBL16020259 | 0.91 | LMNA (0.67) | LMNAKMT2ATDP1CA1CA2 | |
| SCHEMBL12088313 | 0.91 | LMNA (0.67) | LMNAKMT2ATDP1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7670751-B2 | Photoacid generator, resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-03-02 | — | — | US | disclosed |
| US-20090061358-A1 | NOVEL PHOTOACID GENERATOR, RESIST COMPOSITION, AND PATTERNING PROCESS | PROXIMAL SYSTEMS CORPORATION | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090061358-A1 | NOVEL PHOTOACID GENERATOR, RESIST COMPOSITION, AND PATTERNING PROCESS | RER1, CRY1, CYP21A2 | GPBAR1 198/4885LMNA 3801/4885KMT2A 3509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.